Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus intermittent cefotaxime administration in critically ill ICU patients
NL-OMON41771Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cefotaxime in bacterial pneumonia (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Total plasma cefotaxime concentrations, Unbound plasma cefotaxime concentrations and 1 more. Started Dec 2015; status: active, not recruiting.
02
Drugs
cefotaxime
03
Conditions
bacterial pneumonia
Beyond the preview
Go deeper on NL-OMON41771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41771.